Correlation Between Salesforce and XSpray Pharma

Can any of the company-specific risk be diversified away by investing in both Salesforce and XSpray Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and XSpray Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salesforce and XSpray Pharma AB, you can compare the effects of market volatilities on Salesforce and XSpray Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of XSpray Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and XSpray Pharma.

Diversification Opportunities for Salesforce and XSpray Pharma

-0.58

Correlation Coefficient

Salesforce  XSpray Pharma

Excellent diversification

The 3 months correlation between Salesforce and XSpray is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and XSpray Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XSpray Pharma AB and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with XSpray Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XSpray Pharma AB has no effect on the direction of Salesforce i.e., Salesforce and XSpray Pharma go up and down completely randomly.

Pair Corralation between Salesforce and XSpray Pharma

Considering the 90-day investment horizon Salesforce is expected to generate 0.17 times more return on investment than XSpray Pharma. However, Salesforce is 5.8 times less risky than XSpray Pharma. It trades about -0.09 of its potential returns per unit of risk. XSpray Pharma AB is currently generating about -0.14 per unit of risk. If you would invest  34,172  in Salesforce on October 26, 2024 and sell it today you would lose (706.00) from holding Salesforce or give up 2.07% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	94.44%
Values	Daily Returns

Salesforce  vs.  XSpray Pharma AB

Salesforce

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.

XSpray Pharma AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days XSpray Pharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Salesforce and XSpray Pharma

The main advantage of trading using opposite Salesforce and XSpray Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, XSpray Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XSpray Pharma will offset losses from the drop in XSpray Pharma's long position.

The idea behind Salesforce and XSpray Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.